Related Experiment Video

Updated: Jun 17, 2026

Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes
13:36

Generation of Monocyte-Derived Dendritic Cells with Differing Sialylated Phenotypes

Published on: October 20, 2023

Antigen presentation by dendritic cells in tumors is disrupted by altered metabolism that involves pyruvate kinase M2

Zhuohan Zhang1, Qiaofei Liu, Yongzhe Che

  • 1Department of Immunology, Nankai University School of Medicine and Key Laboratory of Bioactive Materials, Ministry of Education, Nankai University, Tianjin, People's Republic of China.

Cancer Research
|December 10, 2009
PubMed

Insights

Tumor-derived factors upregulate SOCS3 in dendritic cells (DCs), causing dysfunction. SOCS3 binds to M2-PK, reducing ATP production and impairing anti-tumor immunotherapy by decreasing antigen presentation.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Metabolism

Background:

  • Dendritic cell (DC) function is crucial for anti-tumor immunity but is often suppressed within the tumor microenvironment.
  • The precise mechanisms by which tumors impair DC function remain incompletely understood.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying tumor-induced DC dysfunction.
  • To investigate the role of Suppressor of Cytokine Signaling 3 (SOCS3) and pyruvate kinase type M2 (M2-PK) in DC metabolic regulation and function.

Main Methods:

  • Co-immunoprecipitation assays to detect SOCS3-M2-PK interaction.
  • Measurement of ATP production via glycolysis in DCs.
  • Assessment of DC antigen-presenting capacity.
  • Evaluation of DC-based immunotherapy efficacy in a tumor model.

Main Results:

  • Tumor-derived factors upregulate intracellular SOCS3 expression in DCs.
  • SOCS3 directly binds to M2-PK within DCs.
  • This interaction inhibits M2-PK activity, leading to reduced ATP production through glycolysis.
  • Consequently, DC antigen presentation is impaired, and DC-based anti-tumor immunotherapy is less effective.

Conclusions:

  • Tumor-induced SOCS3 upregulation disrupts DC metabolism by inhibiting M2-PK and reducing ATP levels.
  • This SOCS3-M2-PK interaction represents a novel mechanism of DC dysfunction in the tumor microenvironment.
  • Targeting the SOCS3-M2-PK interaction may restore DC function and enhance anti-tumor immunotherapy.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.